DuPont de Nemours, Inc. · NYSE:DD
DuPont de Nemours — DuPont — FY2014 Earnings Presentation
40 slides from DuPont de Nemours's earnings presentation, Jan 27, 2015
Slide 1: DuPont Fourth Quarter and Full Year 2014 Earnings Conference Call
DuPont Fourth Quarter and Full Year 2014 Earnings Conference Call January 27, 2015
Slide 2: Regulation G and Forward-Looking Statements
Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company. Th
Slide 3: Introductory Remarks
Introductory Remarks • Strong progress in 2014 leaves DuPont poised to deliver higher growth and higher value in 2015 and beyond • Continued portfolio transformation as a dynamic science company driven by innovation, execution, and global reach • Continued focus on innovation and development of new
Slide 4: 4Q 2014 Financial Highlights
4Q 2014 Financial Highlights* $ in millions, except EPS 4Q14 vs. 4Q13 FY14 vs. FY13 EPS* Operating earnings** $0.71 20% $4.01 3% GAAP earnings $0.73 284% $3.90 28% 4Q14 vs. 4Q13 FY14 vs. FY13 Consolidated Net Sales* $7,378 (5%) $34,723 (3%) Volume 3% 1% Local Prices (1%) (1%) Currency Impact (3%) (1
Slide 5: 4Q 2014 Segment Operating Earnings Variance
4Q 2014 Segment Operating Earnings* Variance ($ in millions) $4 $1 ($2) ($16) $38 $9 ($0) $41 $1,014 $939 Segment Segment Operating Operating Earnings* Earnings* 4Q13 Ag Perf Mtls IB E&C N&H Perf Chem S&P Other 4Q14 Key Factors Growth in Agriculture driven by the timing of seed shipments, higher c
Slide 6: Global Sales – Regional Highlights
Global Sales – Regional Highlights 4Q 2014 Sales by Region 4Q 2014 Sales YOY% Change Region % Latin America U.S. & Canada Worldwide -5% 35% 16% U.S. & Canada -3% Developed EMEA -8% Developed Asia 10% Developed Asia -13% Developing EMEA 8% Developing Markets -3% Developing Asia Developed EMEA 16% 15%
Slide 7: 4Q 2014 Operating EPS Variance
4Q 2014 Operating EPS* Variance $0.07 ($0.03) $0.02 $0.09 ($0.03) $0.59 $0.71 Operating* Operating* EPS EPS 4Q13 Segment results Portfolio changes Corp & Interest Exp EGL Lower shares 4Q14 Key Factors • Segment earnings, excluding portfolio changes, were up $0.09, as lower costs and additional gains
Slide 8: Balance Sheet and Cash
Balance Sheet and Cash December 31, 2014 Free Cash Flow Free Cash Flow* • ~$0.4B improvement YOY YTD 13 YTD 14 • Absence of prior-year tax payments related to the 2.0 sale of Performance Coatings 1.5 $ Billions 1.0 Balance Sheet 0.5 • $3.7B net debt** 0.0 • $2.0B in share repurchases – about 30 mill
Slide 9: Other Financial Highlights
Other Financial Highlights • Increased total expected cost savings from operational redesign to at least $1.3 billion • Redesign initiative on track and contributed $0.05 per share to operating earnings in the quarter; $0.07 per share for full year 2014 • On track to complete Performance Chemicals s
Slide 10: 2015 Assumptions
2015 Assumptions Macroeconomic Outlook Key Market Summary • Dollar stronger against most • Ag sector remains challenged currencies ⁻ Farmer net income has declined ⁻ Expect lower corn planted area • Global GDP 3% • Global light vehicle builds expected • Industrial Production 3% to rise nearly 3% ⁻ A
Slide 11: 2015 Expectations and Outlook
2015 Expectations and Outlook • Net sales even with prior year, ~5 percent growth from volume and local price offset by portfolio changes and impact of currency • Operating EPS* earnings range of $4.00 - $4.20 per share • Includes Performance Chemicals • Includes currency headwind of ~$0.60 per shar
Slide 12: Agriculture
Agriculture Pioneer, Crop Protection 4Q Sales* 4Q Comments • Sales - 4 percent lower as a 5 percent increase in volumes was offset by 8 percent lower USD pricing from both currency and local price and a 1 percent decline from portfolio 2.0 • Volume growth from crop protection and the timing of seed
Slide 13: Performance Materials
Performance Materials*** Performance Polymers (DPP), Packaging & Industrial Polymers (P&IP) 4Q Sales* 4Q Comments • Sales - Positive volume and local pricing were more than offset 2.0 by currency and portfolio impact, resulting in a decline of 4 percent 1.6 • Segment volume increased 4 percent on so
Slide 14: Industrial Biosciences
Industrial Biosciences 4Q Sales* 4Q Comments • Sales - Down 1 percent as 2 percent higher volumes were 0.4 more than offset by the impact of currency 0.3 • Growth in enzymes driven by new product offerings and $ in Billions increased sales into emerging markets 0.2 • Biomaterial sales were lower on
Slide 15: Electronics & Communications
Electronics & Communications 4Q Sales* 4Q Comments • Sales - Down 11 percent on lower volumes and lower metals 1.0 prices 0.8 • Volume growth in several product lines was more than offset $ in Billions 0.6 by competitive pressures impacting Solamet® paste 0.4 • Operating Earnings - Up 4 percent as l
Slide 16: Nutrition & Health
Nutrition & Health 4Q Sales* 4Q Comments • Sales - Volume growth in cultures and probiotics was more 1.0 than offset by the negative impact of currency 0.8 • Operating Earnings - Increased 1% as the negative impact of $ in Billions 0.6 currency and unfavorable mix were offset by a gain on 0.4 termin
Slide 17: Safety & Protection
Safety & Protection Protection Technologies (DPT), Building Innovations (BI), Sustainable Solutions (DSS) 4Q Sales* 4Q Comments • Sales - 3 percent volume growth was more than offset by 1.2 currency and portfolio impact 1.0 • Increased demand in industrial markets for Nomex® thermal $ in Billions 0.
Slide 18: Performance Chemicals
Performance Chemicals*** Titanium Technologies (DTT), Chemical & Fluoroproducts (DC&F) 4Q Sales* 4Q Comments • Sales - Down 6 percent due primarily to a 5 percent negative 2.0 portfolio impact 1.5 • Segment volumes were up 3 percent on solid demand for chemicals $ in Billions and fluoroproducts, 1.0
Slide 19: Appendix 1: Fourth Quarter 2014 Segment Commentary
APPENDIX 1: FOURTH QUARTER 2014 SEGMENT COMMENTARY This data should be read in conjunction with the Company’s fourth quarter earnings news release dated January 27, 2015, DuPont’s 4Q 2014 Earnings Conference Call presentation materials and reconciliations of non-GAAP to GAAP measures included in the
Slide 20: Segment Commentary: Agriculture
Segment Commentary Fourth Quarter Earnings 2014 Agriculture In our Agriculture segment, fourth quarter sales are largely driven by the summer and Safrinha seasons in Latin America and shipments to customers in advance of the 2015 planting season in the northern hemisphere. Sales for the quarter were
Slide 21: Segment Commentary: Agriculture (continued)
Segment Commentary Fourth Quarter Earnings 2014 Agriculture (continued) As we look to the near future, we expect the economic environment in the agriculture sector to remain challenged. Farmer net income has declined and growers in Brazil’s Safrinha season and in North America are likely to reduce c
Slide 22: Segment Commentary: Agriculture (continued)
Segment Commentary Fourth Quarter Earnings 2014 Agriculture (continued) While agriculture markets may continue to face challenges in the short-term, we remain confident in the long-term fundamentals for sustainable demand growth for grain and oilseeds and in our growth strategy. We are excited about
Slide 23: Segment Commentary: Performance Materials
Segment Commentary Fourth Quarter Earnings 2014 Performance Materials Positive volume and local pricing were more than offset by currency and portfolio impact, resulting in a sales decline of 4 percent. Segment volumes increased 4 percent on solid demand in auto, packaging, industrial, and consumer
Slide 24: Segment Commentary: Industrial Biosciences
Segment Commentary Fourth Quarter Earnings 2014 Industrial Biosciences Industrial Biosciences sales of $322 million were 1 percent lower as 2 percent higher volumes were more than offset by the impact of currency. Growth in enzymes was driven by new product offerings and increased sales into emergin
Slide 25: Segment Commentary: Electronics & Communications
Segment Commentary Fourth Quarter Earnings 2014 Electronics & Communications Sales in Electronics & Communications were 11 percent lower in the fourth quarter. Volume growth in several product lines was more than offset by competitive pressures impacting Solamet® paste and the pass-through of lower
Slide 26: Segment Commentary: Nutrition & Health
Segment Commentary Fourth Quarter Earnings 2014 Nutrition & Health In Nutrition & Health, sales were 3 percent lower as continued volume growth in cultures and probiotics was more than offset by the negative impact of currency. Operating earnings increased $1 million as the negative impact of curren
Slide 27: Segment Commentary: Safety & Protection
Segment Commentary Fourth Quarter Earnings 2014 Safety & Protection Sales of $943 million were down 3 percent as volume growth was more than offset by the impact of the Sontara® divestiture. Higher volumes in industrial markets, including demand for Nomex® thermal resistant fiber, Kevlar® high stren
Slide 28: Segment Commentary: Performance Chemicals
Segment Commentary Fourth Quarter Earnings 2014 Performance Chemicals Sales were down 6 percent due primarily to a 5 percent negative portfolio impact. Volumes were up 3 percent on solid demand for chemicals and fluoroproducts. In Ti02, volumes were flat and prices were down 7 percent from the prior
Slide 29: Quarterly Supplemental Financial Data and Non-GAAP Reconciliations
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES QUARTERLY SUPPLEMENTAL FINANCIAL DATA AND NON-GAAP RECONCILIATIONS (UNAUDITED) DECEMBER 31, 2014 INDEX PAGE SELECTED OPERATING RESULTS 28 SELECTED INCOME STATEMENT DATA 29 SEGMENT SALES 30 SEGMENT PRETAX OPERATING INCOME 31 SEGMENT O
Slide 30: Selected Operating Results
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SELECTED OPERATING RESULTS (UNAUDITED) (dollars in millions) Year Year Year Year 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 INCOME STATEMENT DATA Consolidated Net Sales 34,723 7,378 7,511 9,706 10
Slide 31: Selected Income Statement Data – Operating Earnings
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SELECTED INCOME STATEMENT DATA OPERATING EARNINGS (UNAUDITED) (dollars in millions, except per share) Year Year Year Year 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Consolidated Net Sales 34,723 7
Slide 32: Segment Sales
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SEGMENT SALES (UNAUDITED) (dollars in millions) SEGMENT SALES Year Year Year Year 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Agriculture 11,304 1,732 1,563 3,615 4,394 11,739 1,806 1,633 3,631 4,6
Slide 33: Income from Continuing Operations – Segment Pretax Operating Income
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES INCOME FROM CONTINUING OPERATIONS (UNAUDITED) (dollars in millions) SEGMENT PRETAX OPERATING INCOME (LOSS) Year Year Year Year 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Agriculture 2,668 492 (55)
Slide 34: Operating Earnings
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES OPERATING EARNINGS (UNAUDITED) (dollars in millions) SEGMENT OPERATING EARNINGS Year Year Year Year 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Agriculture 2,352 129 (55) 836 1,442 2,483 88 (62) 94
Slide 35: Significant Items by Segment – Pretax Operating Income
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SIGNIFICANT ITEMS BY SEGMENT - PRETAX OPERATING INCOME (UNAUDITED) (dollars in millions) SEGMENT PRETAX IMPACT OF Year Year Year Year SIGNIFICANT ITEMS 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 A
Slide 36: Reconciliation of Non-GAAP Measures
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions, except per share) Year Year Year Year 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 RECONCILIATION OF DILUTED EPS (1) Operating E
Slide 37: Reconciliation of Non-GAAP Measures – Net Debt
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions) Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 CALCULATION OF NET DEBT Cash and Cash Equivalents 6,910 3,982 4,174 3,78
Slide 38: Reconciliation of Non-GAAP Measures – Segment Margins
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) Year Year Year Year 2014 4Q14 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 SEGMENT PTOI MARGIN % (PTOI / Segment Sales) (1) Agriculture 23.6% 28.4% -3.5% 21.8%
Slide 39: Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF BASE INCOME TAX RATE TO EFFECTIVE INCOME TAX RATE (UNAUDITED) Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items and non-operating pension/
Slide 40: The DuPont DuPont Oval Oval Logo,
Copyright©©2014 Copyright 2015DuPont DuPontororitsits affiliates. affiliates. All All rights rights reserved. reserved. The DuPont DuPontOval OvalLogo, Logo,DuPont™, DuPont™, The Themiracles miracles of science™ of science™ and all and all products products, unlessdenoted otherwise with indicated, ™